Preparation and characterization of inclusion complexes of antitumor camptothecin with cucurbit[n = 7, 8]urils

Science China Chemistry

Volumn 53, Issue 11, 2010, Pages 2304-2310

  Dong, Nan ^a   Dong, Meiyu ^a   Zhao, Anting ^a   Zhu, Qianjiang ^a   Tao, Zhu ^a   Zhao, Yu ^b  

^a GUIZHOU UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

camptothecin; complexes; cucurbit n uril (n = 7, 8); dissolution properties; stability

Indexed keywords

ANTI-TUMORS; ANTICANCER DRUG; AQUEOUS SOLUBILITY; AQUEOUS SOLUTIONS; CAMPTOTHECINS; CO-EVAPORATION METHOD; COMPLEXES; CUCURBIT[N]URIL (N = 7, 8); DISSOLUTION RATES; FOURIER TRANSFORMATIONS; INCLUSION COMPLEX; PHOSPHATE BUFFER SOLUTIONS; PHYSICAL MIXTURES; POWDER X RAY DIFFRACTION; SOLID INCLUSION COMPLEXES; STABILITY CONSTANTS;

BODY FLUIDS; DIFFERENTIAL SCANNING CALORIMETRY; FLUORESCENCE SPECTROSCOPY; FOURIER ANALYSIS; FOURIER TRANSFORMS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; SOLUTIONS; X RAY DIFFRACTION;

DISSOLUTION;

EID: 78649343690     PISSN: 16747291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11426-010-4067-z     Document Type: Article

References (29)

1. M.E. Wall M.C. Wani C.E. Cook 1966 Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from camptotheca acuminata1 J Am Chem Soc 88 3888 3890 1:CAS:528:DyaF28XkvVant7c%3D 10.1021/ja00968a057
2. R.P. Hertzberg M.J. Caranfa K.G. Holden D.R. Jakas G. Gallagher M.R. Mattern S.M. Mong J.O.'.L. Bartus R.K. Johnson W.D. Kingsbury 1989 Modification of the hydroxy lactone ring of camptothecin: Inhibition of mammalian topoisomerase and biological activity J Med Chem 32 715 720 1:CAS:528: DyaL1MXhtFGitL8%3D 10.1021/jm00123a038
3. C.H. Zhou F.F. Zhang L.L. Gan Y.Y. Zhang R.X. Geng 2009 Review on supermolecules as chemical drugs Sci China Series B-Chem 52 4 415 458 1:CAS:528:DC%2BD1MXksFaksL8%3D 10.1007/s11426-009-0103-2
4. K. Uekama F. Hirayama T. Irie 1998 Cyclodextrin drug carrier systems Chem Rev 98 2045 2076 1:CAS:528:DyaK1cXksV2itr0%3D 10.1021/cr970025p
5. J.J. Zhabg Y. Shao L. Wei Y. Li X. Sheng F. Liu G.Y. Lu 2009 Design of artificial nucleases and studies of their interaction with DNA Sci China Series B-Chem 52 4 402 414 10.1007/s11426-009-0029-8
6. J. Kim I.S. Jung S.Y. Kim E. Lee J. Kang K.S. Sakamoto K. Yamaguchi K. Kim 2000 New cucurbituril homologues: Syntheses, isolation, characterization, and X-ray crystal structures of cucurbit[n]uril (n = 5, 7, and 8) J Am Chem Soc 122 540 541 1:CAS:528:DC%2BD3cXhs1Gjtw%3D%3D 10.1021/ja993376p
7. J. Lagona J.C. Fettinger L. Isaacs 2003 Cucurbit[n]uril analogues Org Lett 5 3745 3747 1:CAS:528:DC%2BD3sXnt1Ols7Y%3D 10.1021/ol035468w
8. J.W. Lee S. Samal N. Selvapalam H.J. Kim K. Kim 2003 Cucurbituril homologues and derivatives: New opportunities in supramolecular chemistry Acc Chem Res 36 621 630 1:CAS:528:DC%2BD3sXjvFCnt7s%3D 10.1021/ar020254k
9. K. Kim N. Selvapaam Y.H. Ko K.M. Park D. Kim J. Kim 2007 Functionalized cucurbiturils and their applications Chem Soc Rev 36 267 279 1:CAS:528:DC%2BD2sXhtVKltbw%3D 10.1039/b603088m
10. J.A. Elemans A.W. Rowan A.E. Nolte 2000 Self-assembled architectures from glycoluril Ind Eng Chem Res 39 3419 3428 1:CAS:528:DC%2BD3cXlvVKisL8%3D 10.1021/ie000079g
11. P. Cintas 1994 Cucurbituril: Supramolecular perspectives for an old ligand J Incl Phenom Molec Reco Chem 17 205 220 1:CAS:528:DyaK2cXlsFKkuro%3D 10.1007/BF00708781
12. S.Y. Jon N. Selvapalam D.H. Oh J.K. Kang S.Y. Kim Y.J. Jeon J.W. Lee K. Kim 2003 Facile synthesis of cucurbit[n]uril derivatives via direct functionalization: Expanding utilization of cucurbit[n]uril J Am Chem Soc 125 10186 10187 1:CAS:528:DC%2BD3sXmtVSlsro%3D 10.1021/ja036536c
13. Wheate NJ, Day AI, Blanch RJ, Arnold AP, Cullinance C, Collins JG. Multi-nuclear platinum complexes encapsulated in cucurbit[n]uril as an approach to reduce toxicity in cancer treatment. Chem Commun, 2004, 1424-1425
14. Y.J. Jeon S.Y. Kim Y.H. Ko S. Sakamoto K. Yamagchi K. Kim 2005 Novel molecular drug carrier: Encapsulation of oxaliplatin in cucurbit[7]uril and its effects on stability and reactivity of the drug Org Biomol Chem 3 2122 2125 1:CAS:528:DC%2BD2MXksFaquro%3D 10.1039/b504487a
15. Y. Huang S.F. Xue Z. Tao 2008 Inclusion interaction between cucurbit[7]uril with Adenine and its derivatives Supramol Chem 20 279 287 1:CAS:528:DC%2BD1cXjsFCntLo%3D 10.1080/10610270701218570
16. L.X. Liu S.Y. Zhu 2007 A study on the supramolecular structure of inclusion complex of β-cyclodextrin with prazosin hydrochloride Carbohyd Polym 68 472 476 1:CAS:528:DC%2BD2sXislWhu74%3D 10.1016/j.carbpol.2006.11.007
17. K.A. Khan 1975 The concept of dissolution efficiency J Pharm Pharmacol 27 48 49 1:CAS:528:DyaE2MXhsVCru7o%3D
18. H. Cong L.L. Tao Y.H. Yu F. Yang Y. Du S.F. Xue Z. Tao 2006 Molecular recognition of aminoacid by cucurbiturils Acta Chim Sin 64 989 996 1:CAS:528:DC%2BD28XlsVOgur8%3D
19. F. Giordano C. Novak J.R. Moyano 2001 Thermal analysis of cyclodextrins and their inclusion compounds Therm Acta 380 123 151 1:CAS:528: DC%2BD3MXos1ChsL0%3D 10.1016/S0040-6031(01)00665-7
20. M.A. Ruiz I. Reyes A. Parera V. Gallardo 1998 Determination of the stability of omeprazole by means of different scanning calorimetry J Therm Anal 51 29 35 1:CAS:528:DyaK1cXns1ahsLY%3D 10.1007/BF02719008
21. L.M.A. Pinto L.F. Fraceto M.H.A. Santana T.A. Pertinhez S.O. Junior E.D. Paula 2005 Physico-chemical characterization of benzocaine-β-cyclodextrin inclusion complexes J Pharm Biom Anal 39 956 963 1:CAS:528:DC%2BD2MXhtFWht7%2FN 10.1016/j.jpba.2005.06.010
22. L. Ning Y.H. Zhang Y.N. Wu X.L. Xiong Y.H. Zhang 2005 Inclusion complex of trimethoprim with β-cyclodextrin (short communication) J Pharm Biom Anal 39 824 829 10.1016/j.jpba.2005.05.011
23. G. Zingone F. Rubessa 2005 Preformulation study of the inclusion complex warfarin-[beta]-cyclodextrin Int J Pharm 291 3 10 1:CAS:528:DC%2BD2MXhtFejtLY%3D 10.1016/j.ijpharm.2004.11.013
24. K.L. Yap X. Liu J.C. Thenmozhiyal P.C. Ho 2005 Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis Eur J Pharm Sci 25 49 56 1:CAS:528:DC%2BD2MXjs1Knu7c%3D 10.1016/j.ejps.2005.01.021
25. K. Rajendrakumar S. Madhusudan T. Pralhad 2005 Cyclodextrin complexes of valdecoxib: Properties and anti-inflammatory activity in rat Eur J Pharm Biopharm 60 39 46 1:CAS:528:DC%2BD2MXjsVehsbg%3D 10.1016/j.ejpb.2004.12.005
26. H.C. Marques J. Hadgraft I. Kellaway 1990 Studies of cyclodextrin inclusion complexes. I. The salbutamol-cyclodextrin complex as studied by phase solubility and DSC Int J Pharm 63 259 266 10.1016/0378-5173(90)90132-N
27. C.Y. Xu M.Z. Huang C.X. Xue 2005 Synthesis and spectral characterization of 10-hydroxycamptothecin Spectrosc Spect Anal 25 1772 1774 1:CAS:528: DC%2BD2MXhtlWjtL%2FO
28. A. Figuerias R.A. Carvalho L. Ribeiro J.J. Torres-Labandeira F.J.B. Veiga 2007 Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified β-cyclodextrin Eur J Pharm Biopharm 67 531 539 10.1016/j.ejpb.2007.03.005
29. H.G. Lerchen J. Baumgarten K.V.D. Bruch T.E. Lehmann M. Sperzel G. Kempka H.H. Fiebig 2001 Design and optimization of 20-o-linked camptothecin glycoconjugates as anticancer agents J Med Chem 44 4186 4195 1:CAS:528:DC%2BD3MXnslOhsbY%3D 10.1021/jm010893l